BUFFALO, N.Y. — A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a direct causal link with the drugs has not been established.

A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a direct causal link with the drugs has not been established. That is the ...

Canadian study reveals diabetic patients taking GLP-1 medications face twice the risk of eye problems, with longer exposure ...

Researchers suggest people taking Ozempic and similar drugs may face double the risk of developing wet age-related macular ...

JAMA Ophthalmology (formerly Archives of Ophthalmology) is a monthly professional medical journal published by the American Medical Association. Archives of Ophthalmology publishes peer-reviewed ...

JAMA Ophthalmology Source Reference: Etminan M, et al "GLP-1 RAs and nonarteritic anterior ischemic optic neuropathy -- making sense of the data" JAMA Ophthalmol 2025; DOI: 10.1001/jamaophthalmol ...

New research links semaglutide and tirzepatide, which are GLP-1 agonists used to treat type 2 diabetes and aid weight loss, ...

Mismatch repair (MMR) germline alterations are enriched among patients with uveal melanoma (UM), according to a study ...

Bernie was born with congenital glaucoma, a condition that requires urgent intervention. A team of pediatric ophthalmologists ...

JAMA Ophthalmology Source Reference: Jampol LM, Maguire MG "No red flags for risk of retinal vascular occlusion after mRNA COVID-19 vaccination" JAMA Ophthalmol 2023; DOI: 10.1001/jamaophthalmol ...

A new study in JAMA Ophthalmology highlights the importance for people with type 2 diabetes who take GLP-1 medicines to contact their health care provider immediately if they experience any vision ...

The study, published in JAMA Ophthalmology and led by St. Michael's Hospital, a site of Unity Health Toronto, found ChatGPT correctly answered 46 per cent of questions when initially conducted in ...